Showing results (1631-1640 of 1,660) with videos related to

Sort By:
Pageof 166
BJS Open|November 5, 2025
Risk factors for hepatocellular carcinoma rupture: multicentre retrospective studyFeng Xia, Yiyang Liu, Hongwei Huang, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Journal of Medicinal Chemistry|May 27, 2016
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical DevelopmentJames F Blake, Michael Burkard, Jocelyn Chan, et al.
Science China. Life Sciences|September 14, 2025
A novel pathologic scoring system for predicting postoperative recurrence in BCLC stage 0-A hepatocellular carcinoma patients: a nationwide multicenter studyFeng Xia, Jing Yan, Xulin Liu, et al.
American Journal of Translational Research|January 11, 2023
The prognostic value of keratin pearls in patients with esophageal squamous cell carcinomaKan Zhong, Xin Song, Xue Ke Zhao, et al.
Cell|April 12, 2024
A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2Li Ren Kong, Komal Gupta, Andy Jialun Wu, et al.
Frontiers in Oncology|March 3, 2023
Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinomaJing Feng Hu, Xin Song, Kan Zhong, et al.
Cell Reports|May 28, 2024
Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell systemCherif Badja, Sophie Momen, Gene Ching Chiek Koh, et al.
Military Medical Research|February 17, 2021
Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreakGuang-Li Ren, Xian-Feng Wang, Jun Xu, et al.
The Lancet. Oncology|January 18, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trialWan-Qin Chong, Jia-Li Low, Joshua K Tay, et al.
Pageof 166